世界の核内受容体ROR-ガンマ市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Nuclear Receptor ROR-Gamma Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5900
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、125ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、核内受容体ROR-ガンマの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（VPR-66、INV-17、GSK-2981278、BBI-6000、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・核内受容体ROR-ガンマの市場動向
・企業の競争状況、市場シェア
・核内受容体ROR-ガンマの種類別市場規模と予測2016-2027（VPR-66、INV-17、GSK-2981278、BBI-6000、その他）
・核内受容体ROR-ガンマの用途別市場規模と予測2016-2027（病院、クリニック、その他）
・核内受容体ROR-ガンマの北米市場規模2016-2027（アメリカ、カナダ）
・核内受容体ROR-ガンマの欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・核内受容体ROR-ガンマのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・核内受容体ROR-ガンマの中南米市場規模2016-2027（メキシコ、ブラジル）
・核内受容体ROR-ガンマの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（4SC AG、Advinus Therapeutics Ltd.、Arrien Pharmaceuticals, LLC、Aurigene Discovery Technologies Limited、Biogen, Inc.、Brickell Biotech, Inc.、Bristol-Myers Squibb Company、Celgene Corporation、Genentech, Inc.、Genfit SA、GlaxoSmithKline Plc、Hanmi Pharmaceuticals, Co. Ltd.、Karo Bio AB、Lead Pharma Holding B.V.、Nuevolution AB、Phenex Pharmaceuticals AG、Reata Pharmaceuticals, Inc.、Teijin Pharma Limited、Visionary Pharmaceuticals, Inc.、Vitae Pharmaceuticals, Inc.）
・結論

Market Analysis and Insights: Global Nuclear Receptor ROR-Gamma Market
The global Nuclear Receptor ROR-Gamma market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nuclear Receptor ROR-Gamma market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nuclear Receptor ROR-Gamma market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nuclear Receptor ROR-Gamma market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nuclear Receptor ROR-Gamma market.

Global Nuclear Receptor ROR-Gamma Scope and Market Size
Nuclear Receptor ROR-Gamma market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nuclear Receptor ROR-Gamma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
VPR-66
INV-17
GSK-2981278
BBI-6000
Others

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
4SC AG
Advinus Therapeutics Ltd.
Arrien Pharmaceuticals, LLC
Aurigene Discovery Technologies Limited
Biogen, Inc.
Brickell Biotech, Inc.
Bristol-Myers Squibb Company
Celgene Corporation
Genentech, Inc.
Genfit SA
GlaxoSmithKline Plc
Hanmi Pharmaceuticals, Co. Ltd.
Karo Bio AB
Lead Pharma Holding B.V.
Nuevolution AB
Phenex Pharmaceuticals AG
Reata Pharmaceuticals, Inc.
Teijin Pharma Limited
Visionary Pharmaceuticals, Inc.
Vitae Pharmaceuticals, Inc.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nuclear Receptor ROR-Gamma Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 VPR-66
1.2.3 INV-17
1.2.4 GSK-2981278
1.2.5 BBI-6000
1.2.6 Others
1.3 Market by Application
1.3.1 Global Nuclear Receptor ROR-Gamma Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Nuclear Receptor ROR-Gamma Market Perspective (2016-2027)
2.2 Nuclear Receptor ROR-Gamma Growth Trends by Regions
2.2.1 Nuclear Receptor ROR-Gamma Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Nuclear Receptor ROR-Gamma Historic Market Share by Regions (2016-2021)
2.2.3 Nuclear Receptor ROR-Gamma Forecasted Market Size by Regions (2022-2027)
2.3 Nuclear Receptor ROR-Gamma Industry Dynamic
2.3.1 Nuclear Receptor ROR-Gamma Market Trends
2.3.2 Nuclear Receptor ROR-Gamma Market Drivers
2.3.3 Nuclear Receptor ROR-Gamma Market Challenges
2.3.4 Nuclear Receptor ROR-Gamma Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Nuclear Receptor ROR-Gamma Players by Revenue
3.1.1 Global Top Nuclear Receptor ROR-Gamma Players by Revenue (2016-2021)
3.1.2 Global Nuclear Receptor ROR-Gamma Revenue Market Share by Players (2016-2021)
3.2 Global Nuclear Receptor ROR-Gamma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Nuclear Receptor ROR-Gamma Revenue
3.4 Global Nuclear Receptor ROR-Gamma Market Concentration Ratio
3.4.1 Global Nuclear Receptor ROR-Gamma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nuclear Receptor ROR-Gamma Revenue in 2020
3.5 Nuclear Receptor ROR-Gamma Key Players Head office and Area Served
3.6 Key Players Nuclear Receptor ROR-Gamma Product Solution and Service
3.7 Date of Enter into Nuclear Receptor ROR-Gamma Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Nuclear Receptor ROR-Gamma Breakdown Data by Type
4.1 Global Nuclear Receptor ROR-Gamma Historic Market Size by Type (2016-2021)
4.2 Global Nuclear Receptor ROR-Gamma Forecasted Market Size by Type (2022-2027)

5 Nuclear Receptor ROR-Gamma Breakdown Data by Application
5.1 Global Nuclear Receptor ROR-Gamma Historic Market Size by Application (2016-2021)
5.2 Global Nuclear Receptor ROR-Gamma Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Nuclear Receptor ROR-Gamma Market Size (2016-2027)
6.2 North America Nuclear Receptor ROR-Gamma Market Size by Type
6.2.1 North America Nuclear Receptor ROR-Gamma Market Size by Type (2016-2021)
6.2.2 North America Nuclear Receptor ROR-Gamma Market Size by Type (2022-2027)
6.2.3 North America Nuclear Receptor ROR-Gamma Market Size by Type (2016-2027)
6.3 North America Nuclear Receptor ROR-Gamma Market Size by Application
6.3.1 North America Nuclear Receptor ROR-Gamma Market Size by Application (2016-2021)
6.3.2 North America Nuclear Receptor ROR-Gamma Market Size by Application (2022-2027)
6.3.3 North America Nuclear Receptor ROR-Gamma Market Size by Application (2016-2027)
6.4 North America Nuclear Receptor ROR-Gamma Market Size by Country
6.4.1 North America Nuclear Receptor ROR-Gamma Market Size by Country (2016-2021)
6.4.2 North America Nuclear Receptor ROR-Gamma Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Nuclear Receptor ROR-Gamma Market Size (2016-2027)
7.2 Europe Nuclear Receptor ROR-Gamma Market Size by Type
7.2.1 Europe Nuclear Receptor ROR-Gamma Market Size by Type (2016-2021)
7.2.2 Europe Nuclear Receptor ROR-Gamma Market Size by Type (2022-2027)
7.2.3 Europe Nuclear Receptor ROR-Gamma Market Size by Type (2016-2027)
7.3 Europe Nuclear Receptor ROR-Gamma Market Size by Application
7.3.1 Europe Nuclear Receptor ROR-Gamma Market Size by Application (2016-2021)
7.3.2 Europe Nuclear Receptor ROR-Gamma Market Size by Application (2022-2027)
7.3.3 Europe Nuclear Receptor ROR-Gamma Market Size by Application (2016-2027)
7.4 Europe Nuclear Receptor ROR-Gamma Market Size by Country
7.4.1 Europe Nuclear Receptor ROR-Gamma Market Size by Country (2016-2021)
7.4.2 Europe Nuclear Receptor ROR-Gamma Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size (2016-2027)
8.2 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Type
8.2.1 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Type (2016-2027)
8.3 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Application
8.3.1 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Application (2016-2027)
8.4 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Region
8.4.1 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Nuclear Receptor ROR-Gamma Market Size (2016-2027)
9.2 Latin America Nuclear Receptor ROR-Gamma Market Size by Type
9.2.1 Latin America Nuclear Receptor ROR-Gamma Market Size by Type (2016-2021)
9.2.2 Latin America Nuclear Receptor ROR-Gamma Market Size by Type (2022-2027)
9.2.3 Latin America Nuclear Receptor ROR-Gamma Market Size by Type (2016-2027)
9.3 Latin America Nuclear Receptor ROR-Gamma Market Size by Application
9.3.1 Latin America Nuclear Receptor ROR-Gamma Market Size by Application (2016-2021)
9.3.2 Latin America Nuclear Receptor ROR-Gamma Market Size by Application (2022-2027)
9.3.3 Latin America Nuclear Receptor ROR-Gamma Market Size by Application (2016-2027)
9.4 Latin America Nuclear Receptor ROR-Gamma Market Size by Country
9.4.1 Latin America Nuclear Receptor ROR-Gamma Market Size by Country (2016-2021)
9.4.2 Latin America Nuclear Receptor ROR-Gamma Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size (2016-2027)
10.2 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Type
10.2.1 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Type (2016-2027)
10.3 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Application
10.3.1 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Application (2016-2027)
10.4 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Country
10.4.1 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 4SC AG
11.1.1 4SC AG Company Details
11.1.2 4SC AG Business Overview
11.1.3 4SC AG Nuclear Receptor ROR-Gamma Introduction
11.1.4 4SC AG Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.1.5 4SC AG Recent Development
11.2 Advinus Therapeutics Ltd.
11.2.1 Advinus Therapeutics Ltd. Company Details
11.2.2 Advinus Therapeutics Ltd. Business Overview
11.2.3 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Introduction
11.2.4 Advinus Therapeutics Ltd. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.2.5 Advinus Therapeutics Ltd. Recent Development
11.3 Arrien Pharmaceuticals, LLC
11.3.1 Arrien Pharmaceuticals, LLC Company Details
11.3.2 Arrien Pharmaceuticals, LLC Business Overview
11.3.3 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Introduction
11.3.4 Arrien Pharmaceuticals, LLC Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.3.5 Arrien Pharmaceuticals, LLC Recent Development
11.4 Aurigene Discovery Technologies Limited
11.4.1 Aurigene Discovery Technologies Limited Company Details
11.4.2 Aurigene Discovery Technologies Limited Business Overview
11.4.3 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Introduction
11.4.4 Aurigene Discovery Technologies Limited Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.4.5 Aurigene Discovery Technologies Limited Recent Development
11.5 Biogen, Inc.
11.5.1 Biogen, Inc. Company Details
11.5.2 Biogen, Inc. Business Overview
11.5.3 Biogen, Inc. Nuclear Receptor ROR-Gamma Introduction
11.5.4 Biogen, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.5.5 Biogen, Inc. Recent Development
11.6 Brickell Biotech, Inc.
11.6.1 Brickell Biotech, Inc. Company Details
11.6.2 Brickell Biotech, Inc. Business Overview
11.6.3 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Introduction
11.6.4 Brickell Biotech, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.6.5 Brickell Biotech, Inc. Recent Development
11.7 Bristol-Myers Squibb Company
11.7.1 Bristol-Myers Squibb Company Company Details
11.7.2 Bristol-Myers Squibb Company Business Overview
11.7.3 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Introduction
11.7.4 Bristol-Myers Squibb Company Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.7.5 Bristol-Myers Squibb Company Recent Development
11.8 Celgene Corporation
11.8.1 Celgene Corporation Company Details
11.8.2 Celgene Corporation Business Overview
11.8.3 Celgene Corporation Nuclear Receptor ROR-Gamma Introduction
11.8.4 Celgene Corporation Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.8.5 Celgene Corporation Recent Development
11.9 Genentech, Inc.
11.9.1 Genentech, Inc. Company Details
11.9.2 Genentech, Inc. Business Overview
11.9.3 Genentech, Inc. Nuclear Receptor ROR-Gamma Introduction
11.9.4 Genentech, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.9.5 Genentech, Inc. Recent Development
11.10 Genfit SA
11.10.1 Genfit SA Company Details
11.10.2 Genfit SA Business Overview
11.10.3 Genfit SA Nuclear Receptor ROR-Gamma Introduction
11.10.4 Genfit SA Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.10.5 Genfit SA Recent Development
11.11 GlaxoSmithKline Plc
11.11.1 GlaxoSmithKline Plc Company Details
11.11.2 GlaxoSmithKline Plc Business Overview
11.11.3 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Introduction
11.11.4 GlaxoSmithKline Plc Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.11.5 GlaxoSmithKline Plc Recent Development
11.12 Hanmi Pharmaceuticals, Co. Ltd.
11.12.1 Hanmi Pharmaceuticals, Co. Ltd. Company Details
11.12.2 Hanmi Pharmaceuticals, Co. Ltd. Business Overview
11.12.3 Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Introduction
11.12.4 Hanmi Pharmaceuticals, Co. Ltd. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.12.5 Hanmi Pharmaceuticals, Co. Ltd. Recent Development
11.13 Karo Bio AB
11.13.1 Karo Bio AB Company Details
11.13.2 Karo Bio AB Business Overview
11.13.3 Karo Bio AB Nuclear Receptor ROR-Gamma Introduction
11.13.4 Karo Bio AB Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.13.5 Karo Bio AB Recent Development
11.14 Lead Pharma Holding B.V.
11.14.1 Lead Pharma Holding B.V. Company Details
11.14.2 Lead Pharma Holding B.V. Business Overview
11.14.3 Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Introduction
11.14.4 Lead Pharma Holding B.V. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.14.5 Lead Pharma Holding B.V. Recent Development
11.15 Nuevolution AB
11.15.1 Nuevolution AB Company Details
11.15.2 Nuevolution AB Business Overview
11.15.3 Nuevolution AB Nuclear Receptor ROR-Gamma Introduction
11.15.4 Nuevolution AB Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.15.5 Nuevolution AB Recent Development
11.16 Phenex Pharmaceuticals AG
11.16.1 Phenex Pharmaceuticals AG Company Details
11.16.2 Phenex Pharmaceuticals AG Business Overview
11.16.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Introduction
11.16.4 Phenex Pharmaceuticals AG Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.16.5 Phenex Pharmaceuticals AG Recent Development
11.17 Reata Pharmaceuticals, Inc.
11.17.1 Reata Pharmaceuticals, Inc. Company Details
11.17.2 Reata Pharmaceuticals, Inc. Business Overview
11.17.3 Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Introduction
11.17.4 Reata Pharmaceuticals, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.17.5 Reata Pharmaceuticals, Inc. Recent Development
11.18 Teijin Pharma Limited
11.18.1 Teijin Pharma Limited Company Details
11.18.2 Teijin Pharma Limited Business Overview
11.18.3 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Introduction
11.18.4 Teijin Pharma Limited Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.18.5 Teijin Pharma Limited Recent Development
11.18 Visionary Pharmaceuticals, Inc.
.1 Visionary Pharmaceuticals, Inc. Company Details
.2 Visionary Pharmaceuticals, Inc. Business Overview
.3 Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Introduction
.4 Visionary Pharmaceuticals, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
.5 Visionary Pharmaceuticals, Inc. Recent Development
11.20 Vitae Pharmaceuticals, Inc.
11.20.1 Vitae Pharmaceuticals, Inc. Company Details
11.20.2 Vitae Pharmaceuticals, Inc. Business Overview
11.20.3 Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Introduction
11.20.4 Vitae Pharmaceuticals, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021)
11.20.5 Vitae Pharmaceuticals, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Nuclear Receptor ROR-Gamma Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of VPR-66
Table 3. Key Players of INV-17
Table 4. Key Players of GSK-2981278
Table 5. Key Players of BBI-6000
Table 6. Key Players of Others
Table 7. Global Nuclear Receptor ROR-Gamma Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Nuclear Receptor ROR-Gamma Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Nuclear Receptor ROR-Gamma Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Nuclear Receptor ROR-Gamma Market Share by Regions (2016-2021)
Table 11. Global Nuclear Receptor ROR-Gamma Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Nuclear Receptor ROR-Gamma Market Share by Regions (2022-2027)
Table 13. Nuclear Receptor ROR-Gamma Market Trends
Table 14. Nuclear Receptor ROR-Gamma Market Drivers
Table 15. Nuclear Receptor ROR-Gamma Market Challenges
Table 16. Nuclear Receptor ROR-Gamma Market Restraints
Table 17. Global Nuclear Receptor ROR-Gamma Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Nuclear Receptor ROR-Gamma Market Share by Players (2016-2021)
Table 19. Global Top Nuclear Receptor ROR-Gamma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Receptor ROR-Gamma as of 2020)
Table 20. Ranking of Global Top Nuclear Receptor ROR-Gamma Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Nuclear Receptor ROR-Gamma Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Nuclear Receptor ROR-Gamma Product Solution and Service
Table 24. Date of Enter into Nuclear Receptor ROR-Gamma Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Nuclear Receptor ROR-Gamma Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Type (2016-2021)
Table 28. Global Nuclear Receptor ROR-Gamma Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Nuclear Receptor ROR-Gamma Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Application (2016-2021)
Table 32. Global Nuclear Receptor ROR-Gamma Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Nuclear Receptor ROR-Gamma Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Nuclear Receptor ROR-Gamma Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Nuclear Receptor ROR-Gamma Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Nuclear Receptor ROR-Gamma Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Nuclear Receptor ROR-Gamma Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Nuclear Receptor ROR-Gamma Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Nuclear Receptor ROR-Gamma Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Nuclear Receptor ROR-Gamma Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Nuclear Receptor ROR-Gamma Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Nuclear Receptor ROR-Gamma Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Nuclear Receptor ROR-Gamma Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Nuclear Receptor ROR-Gamma Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Nuclear Receptor ROR-Gamma Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Nuclear Receptor ROR-Gamma Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Nuclear Receptor ROR-Gamma Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Nuclear Receptor ROR-Gamma Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Nuclear Receptor ROR-Gamma Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Nuclear Receptor ROR-Gamma Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Country (2022-2027) & (US$ Million)
Table 64. 4SC AG Company Details
Table 65. 4SC AG Business Overview
Table 66. 4SC AG Nuclear Receptor ROR-Gamma Product
Table 67. 4SC AG Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 68. 4SC AG Recent Development
Table 69. Advinus Therapeutics Ltd. Company Details
Table 70. Advinus Therapeutics Ltd. Business Overview
Table 71. Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Product
Table 72. Advinus Therapeutics Ltd. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 73. Advinus Therapeutics Ltd. Recent Development
Table 74. Arrien Pharmaceuticals, LLC Company Details
Table 75. Arrien Pharmaceuticals, LLC Business Overview
Table 76. Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Product
Table 77. Arrien Pharmaceuticals, LLC Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 78. Arrien Pharmaceuticals, LLC Recent Development
Table 79. Aurigene Discovery Technologies Limited Company Details
Table 80. Aurigene Discovery Technologies Limited Business Overview
Table 81. Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Product
Table 82. Aurigene Discovery Technologies Limited Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 83. Aurigene Discovery Technologies Limited Recent Development
Table 84. Biogen, Inc. Company Details
Table 85. Biogen, Inc. Business Overview
Table 86. Biogen, Inc. Nuclear Receptor ROR-Gamma Product
Table 87. Biogen, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 88. Biogen, Inc. Recent Development
Table 89. Brickell Biotech, Inc. Company Details
Table 90. Brickell Biotech, Inc. Business Overview
Table 91. Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Product
Table 92. Brickell Biotech, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 93. Brickell Biotech, Inc. Recent Development
Table 94. Bristol-Myers Squibb Company Company Details
Table 95. Bristol-Myers Squibb Company Business Overview
Table 96. Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Product
Table 97. Bristol-Myers Squibb Company Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 98. Bristol-Myers Squibb Company Recent Development
Table 99. Celgene Corporation Company Details
Table 100. Celgene Corporation Business Overview
Table 101. Celgene Corporation Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 102. Celgene Corporation Recent Development
Table 103. Genentech, Inc. Company Details
Table 104. Genentech, Inc. Business Overview
Table 105. Genentech, Inc. Nuclear Receptor ROR-Gamma Product
Table 106. Genentech, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 107. Genentech, Inc. Recent Development
Table 108. Genfit SA Company Details
Table 109. Genfit SA Business Overview
Table 110. Genfit SA Nuclear Receptor ROR-Gamma Product
Table 111. Genfit SA Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 112. Genfit SA Recent Development
Table 113. GlaxoSmithKline Plc Company Details
Table 114. GlaxoSmithKline Plc Business Overview
Table 115. GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Product
Table 116. GlaxoSmithKline Plc Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 117. GlaxoSmithKline Plc Recent Development
Table 118. Hanmi Pharmaceuticals, Co. Ltd. Company Details
Table 119. Hanmi Pharmaceuticals, Co. Ltd. Business Overview
Table 120. Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Product
Table 121. Hanmi Pharmaceuticals, Co. Ltd. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 122. Hanmi Pharmaceuticals, Co. Ltd. Recent Development
Table 123. Karo Bio AB Company Details
Table 124. Karo Bio AB Business Overview
Table 125. Karo Bio AB Nuclear Receptor ROR-Gamma Product
Table 126. Karo Bio AB Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 127. Karo Bio AB Recent Development
Table 128. Lead Pharma Holding B.V. Company Details
Table 129. Lead Pharma Holding B.V. Business Overview
Table 130. Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Product
Table 131. Lead Pharma Holding B.V. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 132. Lead Pharma Holding B.V. Recent Development
Table 133. Nuevolution AB Company Details
Table 134. Nuevolution AB Business Overview
Table 135. Nuevolution AB Nuclear Receptor ROR-Gamma Product
Table 136. Nuevolution AB Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 137. Nuevolution AB Recent Development
Table 138. Phenex Pharmaceuticals AG Company Details
Table 139. Phenex Pharmaceuticals AG Business Overview
Table 140. Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Product
Table 141. Phenex Pharmaceuticals AG Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 142. Phenex Pharmaceuticals AG Recent Development
Table 143. Reata Pharmaceuticals, Inc. Company Details
Table 144. Reata Pharmaceuticals, Inc. Business Overview
Table 145. Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product
Table 146. Reata Pharmaceuticals, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 147. Reata Pharmaceuticals, Inc. Recent Development
Table 148. Teijin Pharma Limited Company Details
Table 149. Teijin Pharma Limited Business Overview
Table 150. Teijin Pharma Limited Nuclear Receptor ROR-Gamma Product
Table 151. Teijin Pharma Limited Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 152. Teijin Pharma Limited Recent Development
Table 153. Visionary Pharmaceuticals, Inc. Company Details
Table 154. Visionary Pharmaceuticals, Inc. Business Overview
Table 155. Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product
Table 156. Visionary Pharmaceuticals, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 157. Visionary Pharmaceuticals, Inc. Recent Development
Table 158. Vitae Pharmaceuticals, Inc. Company Details
Table 159. Vitae Pharmaceuticals, Inc. Business Overview
Table 160. Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product
Table 161. Vitae Pharmaceuticals, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2016-2021) & (US$ Million)
Table 162. Vitae Pharmaceuticals, Inc. Recent Development
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nuclear Receptor ROR-Gamma Market Share by Type: 2020 VS 2027
Figure 2. VPR-66 Features
Figure 3. INV-17 Features
Figure 4. GSK-2981278 Features
Figure 5. BBI-6000 Features
Figure 6. Others Features
Figure 7. Global Nuclear Receptor ROR-Gamma Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Nuclear Receptor ROR-Gamma Report Years Considered
Figure 12. Global Nuclear Receptor ROR-Gamma Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Nuclear Receptor ROR-Gamma Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Nuclear Receptor ROR-Gamma Market Share by Regions: 2020 VS 2027
Figure 15. Global Nuclear Receptor ROR-Gamma Market Share by Regions (2022-2027)
Figure 16. Global Nuclear Receptor ROR-Gamma Market Share by Players in 2020
Figure 17. Global Top Nuclear Receptor ROR-Gamma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Receptor ROR-Gamma as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Nuclear Receptor ROR-Gamma Revenue in 2020
Figure 19. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Type (2016-2021)
Figure 20. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Type (2022-2027)
Figure 21. North America Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Nuclear Receptor ROR-Gamma Market Share by Type (2016-2027)
Figure 23. North America Nuclear Receptor ROR-Gamma Market Share by Application (2016-2027)
Figure 24. North America Nuclear Receptor ROR-Gamma Market Share by Country (2016-2027)
Figure 25. United States Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Nuclear Receptor ROR-Gamma Market Share by Type (2016-2027)
Figure 29. Europe Nuclear Receptor ROR-Gamma Market Share by Application (2016-2027)
Figure 30. Europe Nuclear Receptor ROR-Gamma Market Share by Country (2016-2027)
Figure 31. Germany Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Nuclear Receptor ROR-Gamma Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Nuclear Receptor ROR-Gamma Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Nuclear Receptor ROR-Gamma Market Share by Region (2016-2027)
Figure 41. China Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Nuclear Receptor ROR-Gamma Market Share by Type (2016-2027)
Figure 49. Latin America Nuclear Receptor ROR-Gamma Market Share by Application (2016-2027)
Figure 50. Latin America Nuclear Receptor ROR-Gamma Market Share by Country (2016-2027)
Figure 51. Mexico Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Nuclear Receptor ROR-Gamma Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Nuclear Receptor ROR-Gamma Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Nuclear Receptor ROR-Gamma Market Share by Country (2016-2027)
Figure 57. Turkey Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Nuclear Receptor ROR-Gamma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. 4SC AG Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2016-2021)
Figure 61. Advinus Therapeutics Ltd. Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2016-2021)
Figure 62. Arrien Pharmaceuticals, LLC Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2016-2021)
Figure 63. Aurigene Discovery Technologies Limited Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2016-2021)
Figure 64. Biogen, Inc. Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2016-2021)
Figure 65. Brickell Biotech, Inc. Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2016-2021)
Figure 66. Bristol-Myers Squibb Company Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2016-2021)
Figure 67. Celgene Corporation Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2016-2021)
Figure 68. Genentech, Inc. Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2016-2021)
Figure 69. Genfit SA Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2016-2021)
Figure 70. GlaxoSmithKline Plc Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2016-2021)
Figure 71. Hanmi Pharmaceuticals, Co. Ltd. Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2016-2021)
Figure 72. Karo Bio AB Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2016-2021)
Figure 73. Lead Pharma Holding B.V. Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2016-2021)
Figure 74. Nuevolution AB Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2016-2021)
Figure 75. Phenex Pharmaceuticals AG Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2016-2021)
Figure 76. Reata Pharmaceuticals, Inc. Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2016-2021)
Figure 77. Teijin Pharma Limited Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2016-2021)
Figure 78. Visionary Pharmaceuticals, Inc. Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2016-2021)
Figure 79. Vitae Pharmaceuticals, Inc. Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2016-2021)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed

Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size, Status and Forecast 2021-2027
QFJ1-5745 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、γ-アミノ酪酸受容体サブユニットγ2の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（EL-001、LASSBio-785、LASSBio-786、塩酸ミダゾラム、その他）、用途別市場規模（全身麻酔効果...

世界の低親和性免疫グロブリンガンマFc領域受容体II-B市場規模・現状・予測（2021年-2027年）

Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Size, Status and Forecast 2021-2027
QFJ1-5834 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、低親和性免疫グロブリンガンマFc領域受容体II-Bの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（XmAb-7195、BI-1206、MGD-010、SM-201、その他）、用途別市場規模（病院、クリ...

核内受容体ROR-ガンマのグローバル市場調査 2019年

Global Nuclear Receptor ROR-Gamma Market Professional Survey Report 2019
QYR9NV09062 2019年11月14日 111Pages
※本調査レポートは、核内受容体ROR-ガンマの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、VPR-66、INV-17、GSK-2981278、BBI-600...

世界のタンパク質グルタミンガンマグルタミルトランスフェラーゼ2市場規模・現状・予測（2021年-2027年）

Global Protein Glutamine Gamma Glutamyltransferase 2 Market Size, Status and Forecast 2021-2027
QFJ1-5969 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、タンパク質グルタミンガンマグルタミルトランスフェラーゼ2の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CAT-5571、ERW-1041E、ZED-1227、その他）、用途別市場規模（病院、クリニッ...

世界のトロンボポエチン受容体市場規模・現状・予測（2021年-2027年）

Global Thrombopoietin Receptor Market Size, Status and Forecast 2021-2027
QFJ1-6039 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、トロンボポエチン受容体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エルトロンボパグオラミン、GSK-2285921、ロミプロスティム、STST-4、その他）、用途別市場規模（クリニック、病院、その...

世界のソマトスタチン受容体2型市場規模・現状・予測（2021年-2027年）

Global Somatostatin Receptor Type 2 Market Size, Status and Forecast 2021-2027
QFJ1-6017 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、ソマトスタチン受容体2型の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CRN-00808、酢酸ランレオチド、PRL-2903、その他）、用途別市場規模（ホルモン障害、腫瘍、代謝障害、その他）、主要地...

世界のメラノコルチン受容体4市場規模・現状・予測（2021年-2027年）

Global Melanocortin Receptor 4 Market Size, Status and Forecast 2021-2027
QFJ1-5849 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、メラノコルチン受容体4の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ブレメラノチド、コルチコトロピン、コシントロピン、その他）、用途別市場規模（代謝障害、女性健康、泌尿生殖器系、感染症、その他）、主...

世界のトール様受容体8市場規模・現状・予測（2021年-2027年）

Global Toll Like Receptor 8 Market Size, Status and Forecast 2021-2027
QFJ1-6047 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、トール様受容体8の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（JB-6121、IMO-8400、E-6742、DV-1001、その他）、用途別市場規模（アレルギー性鼻炎、大腸がん、B型肝炎、腹膜がん...

世界の核医学治療薬市場規模・現状・予測（2021年-2027年）

Global Nuclear Drug for Therapeutic Market Size, Status and Forecast 2021-2027
QFJ1-5899 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、核医学治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ラジウム-223、ルテチウム-177、ヨウ素-131、その他）、用途別市場規模（甲状腺、骨転移、リンパ腫、その他）、主要地域別市場規模（北米...

世界のトール様受容体3市場規模・現状・予測（2021年-2027年）

Global Toll Like Receptor 3 Market Size, Status and Forecast 2021-2027
QFJ1-6046 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、トール様受容体3の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（P-7、Poly-ICLC、PrEP-001、その他）、用途別市場規模（B型肝炎、肝臓がん、前立腺がん、その他）、主要地域別市場規模（北...

核内受容体ROR-ガンマのグローバル市場調査 2019年 The global Nuclear Receptor ROR-Gamma market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Nuclear Receptor ROR-Gamma volume and value at global level, regional level and company level. From a global per…
世界の低親和性免疫グロブリンガンマFc領域受容体II-B市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market The global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With in…
世界のγ-アミノ酪酸受容体サブユニットγ2市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market The global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard ac…
ガンマアミノ酪酸受容体サブユニットガンマ2のグローバル市場調査 2019年 The global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 volume and value at global level, regiona…
レチノイン酸受容体ガンマのグローバル市場調査 2019年 The global Retinoic Acid Receptor Gamma market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Retinoic Acid Receptor Gamma volume and value at global level, regional level and company level. From a global…